Brimonidine + areds 2
Brimonidine + areds 2 has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Feb 11, 2026: “Structural And Functional Changes And Therapeutic Efficacy In Comorbid Primary Open-Angle Glaucoma And Dry Age-Related Macular Degeneration”.
1 paper studies it1 findingUpdated
See all 1 papers on brimonidine + areds 2
At a glance
The findings reach people, from one lab or study. 1 lab.
“stabilization of visual function was achieved in 87% of eyes.”
- 1 lab
- Human trial1
Studies in people
1 study gave brimonidine + areds 2 to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves visual function87% of eyes | Trial | 184 people60 to 84 yearsOlder adults; comorbid POAG + AMD | International Journal of Medical Sciences And Clinical Research, Feb 11, 2026 |
What did studies of brimonidine + areds 2 find?
1Studies of brimonidine + areds 2 measured one outcome, visual function.
Visual function
upin humans1+87% eyes
1 study
Visual function
upin humans1+87% eyes
Brimonidine + areds 2 improves visual function in humans (comorbid POAG + AMD) (87% of eyes).
“stabilization of visual function was achieved in 87% of eyes.”
Human trialcomorbid POAG + AMDeye
International Journal of Medical Sciences And Clinical Research